awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33562198-314E764D-43D2-4476-B1EB-B2273AAD954E
Q33562198-314E764D-43D2-4476-B1EB-B2273AAD954E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33562198-314E764D-43D2-4476-B1EB-B2273AAD954E
Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation
P2860
Q33562198-314E764D-43D2-4476-B1EB-B2273AAD954E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33562198-314E764D-43D2-4476-B1EB-B2273AAD954E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c23e34583691468ed210de2145dde405195794bd
P2860
Spanish consensus on the use of natalizumab (Tysabri®)-2013.